Clinical Trial Update: Neuro/Sacituzumab Govitecan/Breast Brain Metastasis/Glioblastoma/Ph 0 [EARLY_Phase 1]

View source ↗

Summary

This entry notes the completion of an early-phase trial evaluating sacituzumab govitecan in glioblastoma.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Glioblastoma

Drugs mentioned

• Sacituzumab Govitecan (sacituzumab govitecan)

Snippet

Sponsor: The University of Texas Health Science Center at San Antonio | Conditions: Glioblastoma | EARLY_Phase 1 | Status: COMPLETED